Clinical Trial Update: Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of bortezomib in patients with Stage IIIB or Stage IV non-small cell lung cancer has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Non-small Cell Lung Cancer

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-21